Key Insights: Great Debates & Updates in Hematologic Malignancies 2017 - Plasma Cell Disorders

Submitted by onc_editor on Fri, 01/26/2018 - 16:50

Key Insights: Great Debates & Updates in Hematologic Malignancies 2017 - Plasma Cell Disorders

 

The 9th annual Great Debates and Updates in Hematologic Malignancies was held April 7-8, 2017 in New York, NY and featured engaging debates and didactic lectures by nationally renowned healthcare professionals. In this activity, conference chair Robert Z. Orlowski, MD, PhD outlines the key take-home messages from the session on plasma cell disorders by first outlining the most current evidence-based data for initial, maintenance, and refractory/relapsed therapy. He then provides a further discussion on the importance and utilization of minimal residual disease (MRD) and biomarkers in daily clinical practice.